Sunshine Biopharma (SBFM) Return on Capital Employed Growth (3y) (2019 - 2026)
Sunshine Biopharma (SBFM) Return on Capital Employed Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1,036.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 175.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 120.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 434.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -295.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1,076.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1,898.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Sunshine Biopharma | 1.58 Mn | -12.17 Mn | 2.43 Mn | 9,781.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9,781.00 |
| Mar 31, 2026 | 10,279.00 |
| Dec 31, 2025 | 7,043.00 |
| Sep 30, 2025 | -1,626.00 |
| Jun 30, 2025 | -1,621.00 |
| Mar 31, 2025 | 729.00 |
| Dec 31, 2024 | 8,390.00 |
| Sep 30, 2024 | 12,881.00 |
| Jun 30, 2024 | 15,446.00 |
| Mar 31, 2024 | 29,031.00 |
| Dec 31, 2023 | -24,965.00 |
| Sep 30, 2023 | -23,766.00 |
| Jun 30, 2023 | -24,474.00 |
| Mar 31, 2023 | -21,073.00 |
| Dec 31, 2022 | -18,622.00 |
| Sep 30, 2022 | -7,981.00 |
| Jun 30, 2022 | -26,063.00 |
| Mar 31, 2022 | 144,316.00 |
| Dec 31, 2021 | 44,599.00 |
| Sep 30, 2021 | 15,873.00 |